NA Whole Exome Sequencing Market - Industry Trends and Forecast to 2029

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,500	175 Pages	Data Bridge Market Research	June, 2022	DAABD17292615

Best Price Guarantee
Price	from $3,500
Length	175 Pages
Publisher	Data Bridge Market Research
Published Date	June, 2022
SKU	DAABD17292615

NA Whole Exome Sequencing Market - Industry Trends and Forecast to 2029

North America whole exome sequencing (WES) Market is projected to register a substantial CAGR of 22.0% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2022 to 2029.
Market Segmentation
Whole Exome Sequencing (WES) Market, By Component (Second generation sequencing and Third-Generation sequencing), Product and Service (systems, kits and services), Application (Drug discovery and development, agriculture & animal research, diagnostics, personalized medicine and others ), End User (pharmaceutical & biotechnology companies, academic & research institutes, hospitals, clinical laboratories and others), Distribution Channel (direct trade, retail sales and others), Industry Trends and Forecast to 2029.

Some of the major factors contributing to the growth of the North America whole exome sequencing (WES) market are:
• Increase in the adoption of whole exome sequencing (WES)
• Growing usage of targeted sequencing methods
Market Segmentation
North America Whole Exome Sequencing (WES) market is categorized into four notable segment which is Component, Product and Service, Application, End User and Distribution Channel.
• On the basis of component, the global whole exome sequencing (WES) market is segmented into second generation sequencing and third-generation sequencing.
• On the basis of Product and Service, the global whole exome sequencing (WES) market is segmented into systems, kits and services.
• On the basis of Application, the global whole exome sequencing (WES) market is segmented into drug discovery and development, agriculture & animal research, diagnostics, personalized medicine and others.
• On the basis of End user, the global whole exome sequencing (WES) market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, hospitals, clinical laboratories and others.
• On the basis of Distribution Channel, the global whole exome sequencing (WES) market is segmented into direct trade, retail sales and others.

Market Players

The key market players for North America whole exome sequencing (WES) market are listed below:
• CD Genomics
• Twist Bioscience
• PerkinElmer Genomics (A Subsidiary of PerkinElmer Inc.)
• GeneDx, LLC
• Psomagen

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of North America Whole Exome Sequencing (Wes) Market; 1.4 Currency And Pricing; 1.5 Limitations; 1.6 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Dbmr Tripod Data Validation Model; 2.5 Primary Interviews With Key Opinion Leaders; 2.6 Multivariate Modelling; 2.7 Market Application Coverage Grid; 2.8 Product Type Lifeline Curve; 2.9 Dbmr Market Position Grid; 2.10 Vendor Share Analysis; 2.11 Secondary Sources; 2.12 Assumptions
3 Executive Summary
4 Premium Insight: 4.1 Porter’s Five Forces; 4.2 Pestel Analysis; 4.3 Industrial Insights:; 4.4 Conclusion
5 North America Whole Exome Sequencing Market: Regulations
6 Market Overview: 6.1 Drivers; 6.1.1 Growing Usage Of Targeted Sequencing Methods; 6.1.2 Increase In The Adoption Of Next Generation Sequencing; 6.1.3 Increasing Diagnostics Applications Of Whole Exome Sequencing; 6.1.4 Increase Trend Toward Personalized Medication; 6.2 Restraints; 6.2.1 Less Comprehensive Coverage Of Exons; 6.2.2 Cyber Security Concerns In Genomics; 6.3 Opportunities; 6.3.1 Strategic Initiatives By The Key Market Player; 6.3.2 Increasing Product Launches In Recent Years; 6.4 Challenges; 6.4.1 Lack Of Skilled Professionals; 6.4.2 Ethical And Legal Issues Related To Whole Exome Sequencing
7 North America Whole Exome Sequencing Market, By Component: 7.1 Overview; 7.2 Second-generation Sequencing; 7.2.1 Sequencing By Synthesis (Sbs); 7.2.2 Sequencing By Hybridization (Sbh) And Sequencing By Ligation (Sbl); 7.3 Third-generation Sequencing
8 North America Whole Exome Sequencing Market, By Product And Service: 8.1 Overview; 8.2 Systems; 8.2.1 Hiseq Series; 8.2.1.1 Hiseq 2500; 8.2.1.2 Hiseq 1500; 8.2.2 Miseq Series; 8.2.3 Ion Torrent Platforms; 8.2.3.1 Ion Proton; 8.2.3.2 Ion Pgm; 8.2.4 Others; 8.3 Kits; 8.3.1 Dna Fragmentation, End Repair, A-tailing, And Size Selection Kits; 8.3.2 Library Preparation Kits; 8.3.3 Target Enrichment Kits; 8.3.4 Others; 8.4 Services; 8.4.1 Sequencing Services; 8.4.2 Data Analysis (Bioinformatics) Services; 8.4.3 Others
9 North America Whole Exome Sequencing Market, By Application: 9.1 Overview; 9.2 Drug Discovery And Development; 9.3 Agriculture & Animal Research; 9.4 Diagnostics; 9.5 Personalized Medicine; 9.6 Others
10 North America Whole Exome Sequencing Market, By End User: 10.1 Overview; 10.2 Pharmaceutical & Biotechnology Companies; 10.3 Academic & Research Institutes; 10.4 Hospitals And Clinics; 10.5 Clinical Laboratories; 10.6 Others
11 North America Whole Exome Sequencing Market, By Distribution Channel: 11.1 Overview; 11.2 Direct Trade; 11.3 Retail Sales; 11.4 Others
12 North America Whole Exome Sequencing Market, By Region: 12.1 North America; 12.1.1 U.S.; 12.1.2 Canada; 12.1.3 Mexico
13 North America Whole Exome Sequencing Market: Company Landscape: 13.1 Company Share Analysis: North America
14 Company Profile: 14.1 Perkinelmer Genomics (A Subsidiary Of Perkinelmer Inc.); 14.1.1 Company Snapshot; 14.1.2 Revenue Analysis; 14.1.3 Com Pany Share Analysis; 14.1.4 Product Portfolio; 14.1.5 Recent Developments; 14.2 Merck Kgaa; 14.2.1 Company Snapshot; 14.2.2 Revenue Analysis; 14.2.3 Com Pany Share Analysis; 14.2.4 Product Portfolio; 14.2.5 Recent Developments; 14.3 Exodx (A Part Of Bio-techne); 14.3.1 Company Snapshot; 14.3.2 Revenue Analysis; 14.3.3 Com Pany Share Analysis; 14.3.4 Product Portfolio; 14.3.5 Recent Developments; 14.4 Thermo Fisher Scientific Inc.; 14.4.1 Company Snapshot; 14.4.2 Revenue Analysis; 14.4.3 Com Pany Share Analysis; 14.4.4 Product Portfolio; 14.4.5 Recent Developments; 14.5 Foundation Medicine, Inc. (A Subsidiary Of F. Hoffmann-la Roche Ltd); 14.5.1 Company Snapshot; 14.5.2 Revenue Analysis; 14.5.3 Com Pany Share Analysis; 14.5.4 Product Portfolio; 14.5.5 Recent Developments; 14.6 Azenta Us, Inc.; 14.6.1 Company Snapshot; 14.6.2 Product Portfolio; 14.6.3 Recent Developments; 14.7 Beckman Coulter, Inc; 14.7.1 Company Snapshot; 14.7.2 Revenue Analysis; 14.7.3 Product Portfolio; 14.7.4 Recent Developments; 14.8 Bioneer Corporation; 14.8.1 Company Snapshot; 14.8.2 Revenue Analysis; 14.8.3 Product Portfolio; 14.8.4 Recent Developments; 14.9 Cd Genomics; 14.9.1 Company Snapshot; 14.9.2 Product Portfolio; 14.9.3 Recent Developments; 14.10 Cegat Gmbh; 14.10.1 Company Snapshot; 14.10.2 Product Portfolio; 14.10.3 Recent Developments; 14.11 Eurofins Scientific; 14.11.1 Company Snapshot; 14.11.2 Revenue Analysis; 14.11.3 Product Portfolio; 14.11.4 Recent Developments; 14.12 Genedx, Llc; 14.12.1 Company Snapshot; 14.12.2 Product Portfolio; 14.12.3 Recent Developments; 14.13 Genefirst Limited.; 14.13.1 Company Snapshot; 14.13.2 Product Portfolio; 14.13.3 Recent Developments; 14.14 Illumina, Inc; 14.14.1 Company Snapshot; 14.14.2 Revenue Analysis; 14.14.3 Product Portfolio; 14.14.4 Recent Developments; 14.15 Integrated Dna Technologies, Inc.; 14.15.1 Company Snapshot; 14.15.2 Product Portfolio; 14.15.3 Recent Developments; 14.16 Meridian Bioscience, Inc.; 14.16.1 Company Snapshot; 14.16.2 Revenue Analysis; 14.16.3 Product Portfolio; 14.16.4 Recent Developments; 14.17 Psomagen; 14.17.1 Company Snapshot; 14.17.2 Revenue Analysis; 14.17.3 Product Portfolio; 14.17.4 Recent Developments; 14.18 Qiagen; 14.18.1 Company Snapshot; 14.18.2 Revenue Analysis; 14.18.3 Product Portfolio; 14.18.4 Recent Developments; 14.19 Sophia Genetics; 14.19.1 Company Snapshot; 14.19.2 Revenue Analysis; 14.19.3 Product Portfolio; 14.19.4 Recent Developments; 14.20 Twist Bioscience; 14.20.1 Company Snapshot; 14.20.2 Revenue Analysis; 14.20.3 Product Portfolio; 14.20.4 Recent Developments
15 Questionnaire
16 Related Reports
List Of Tables: Table 1 North America Whole Exome Sequencing Market, By Component, 2020-2029 (Usd Million); Table 2 North America Second-generation Sequencing In Whole Exome Sequencing Market, By Region, 2020-2029 (Usd Million); Table 3 North America Second-generation Sequencing In Whole Exome Sequencing Market, By Component, 2020-2029 (Usd Million); Table 4 North America Third-generation Sequencing In Whole Exome Sequencing Market, By Region, 2020-2029 (Usd Million); Table 5 North America Whole Exome Sequencing Market, By Product And Service, 2020-2029 (Usd Million); Table 6 North America Systems In Whole Exome Sequencing Market, By Region, 2020-2029 (Usd Million); Table 7 North America Systems In Whole Exome Sequencing Market, By Product And Service, 2020-2029 (Usd Million); Table 8 North America Hiseq Series In Whole Exome Sequencing Market, By Product And Service, 2020-2029 (Usd Million); Table 9 North America Ion Torrent Platforms In Whole Exome Sequencing Market, By Product And Service, 2020-2029 (Usd Million); Table 10 North America Kits In Whole Exome Sequencing Market, By Region, 2020-2029 (Usd Million); Table 11 North America Kits In Whole Exome Sequencing Market, By Product And Service, 2020-2029 (Usd Million); Table 12 North America Services In Whole Exome Sequencing Market, By Region, 2020-2029 (Usd Million); Table 13 North America Services In Whole Exome Sequencing Market, By Product And Service, 2020-2029 (Usd Million); Table 14 North America Whole Exome Sequencing Market, By Application, 2020-2029 (Usd Million); Table 15 North America Drug Discovery And Development In Whole Exome Sequencing Market, By Region, 2020-2029 (Usd Million); Table 16 North America Agriculture & Animal Research In Whole Exome Sequencing Market, By Region, 2020-2029 (Usd Million); Table 17 North America Diagnostics In Whole Exome Sequencing Market, By Region, 2020-2029 (Usd Million); Table 18 North America Personalized Medicine In Whole Exome Sequencing Market, By Region, 2020-2029 (Usd Million); Table 19 North America Others In Whole Exome Sequencing Market, By Region, 2020-2029 (Usd Million); Table 20 North America Whole Exome Sequencing Market, By End User, 2020-2029 (Usd Million); Table 21 North America Pharmaceutical & Biotechnology Companies In Whole Exome Sequencing Market, By Region, 2020-2029 (Usd Million); Table 22 North America Academic & Research Institutes In Whole Exome Sequencing Market, By Region, 2020-2029 (Usd Million); Table 23 North America Hospitals And Clinics In Whole Exome Sequencing Market, By Region, 2020-2029 (Usd Million); Table 24 North America Clinical Laboratories In Whole Exome Sequencing Market, By Region, 2020-2029 (Usd Million); Table 25 North America Others In Whole Exome Sequencing Market, By Region, 2020-2029 (Usd Million); Table 26 North America Whole Exome Sequencing Market, By Distribution Channel, 2020-2029 (Usd Million); Table 27 North America Direct Trade In Whole Exome Sequencing Market, By Region, 2020-2029 (Usd Million); Table 28 North America Retail Sales In Whole Exome Sequencing Market, By Region, 2020-2029 (Usd Million); Table 29 North America Others In Whole Exome Sequencing Market, By Region, 2020-2029 (Usd Million); Table 30 North America Whole Exome Sequencing Market, By Country, 2020-2029 (Usd Million); Table 31 North America Whole Exome Sequencing Market, By Component, 2020-2029 (Usd Million); Table 32 North America Second-generation Sequencing In Whole Exome Sequencing Market, By Component, 2020-2029 (Usd Million); Table 33 North America Whole Exome Sequencing Market, By Product And Service, 2020-2029 (Usd Million); Table 34 North America Systems In Whole Exome Sequencing Market, By Product And Service, 2020-2029 (Usd Million); Table 35 North America Hiseq Series In Whole Exome Sequencing Market, By Product And Service, 2020-2029 (Usd Million); Table 36 North America Ion Torrent Platforms In Whole Exome Sequencing Market, By Product And Service, 2020-2029 (Usd Million); Table 37 North America Kits In Whole Exome Sequencing Market, By Product And Service, 2020-2029 (Usd Million); Table 38 North America Services In Whole Exome Sequencing Market, By Product And Service, 2020-2029 (Usd Million); Table 39 North America Whole Exome Sequencing Market, By Application, 2020-2029 (Usd Million); Table 40 North America Whole Exome Sequencing Market, By End User, 2020-2029 (Usd Million); Table 41 North America Whole Exome Sequencing Market, By Distribution Channel, 2020-2029 (Usd Million); Table 42 U.S. Whole Exome Sequencing Market, By Component, 2020-2029 (Usd Million); Table 43 U.S. Second-generation Sequencing In Whole Exome Sequencing Market, By Component, 2020-2029 (Usd Million); Table 44 U.S. Whole Exome Sequencing Market, By Product And Service, 2020-2029 (Usd Million); Table 45 U.S. Systems In Whole Exome Sequencing Market, By Product And Service, 2020-2029 (Usd Million); Table 46 U.S. Hiseq Series In Whole Exome Sequencing Market, By Product And Service, 2020-2029 (Usd Million); Table 47 U.S. Ion Torrent Platforms In Whole Exome Sequencing Market, By Product And Service, 2020-2029 (Usd Million); Table 48 U.S. Kits In Whole Exome Sequencing Market, By Product And Service, 2020-2029 (Usd Million); Table 49 U.S. Services In Whole Exome Sequencing Market, By Product And Service, 2020-2029 (Usd Million); Table 50 U.S. Whole Exome Sequencing Market, By Application, 2020-2029 (Usd Million); Table 51 U.S. Whole Exome Sequencing Market, By End User, 2020-2029 (Usd Million); Table 52 U.S. Whole Exome Sequencing Market, By Distribution Channel, 2020-2029 (Usd Million); Table 53 Canada Whole Exome Sequencing Market, By Component, 2020-2029 (Usd Million); Table 54 Canada Second-generation Sequencing In Whole Exome Sequencing Market, By Component, 2020-2029 (Usd Million); Table 55 Canada Whole Exome Sequencing Market, By Product And Service, 2020-2029 (Usd Million); Table 56 Canada Systems In Whole Exome Sequencing Market, By Product And Service, 2020-2029 (Usd Million); Table 57 Canada Hiseq Series In Whole Exome Sequencing Market, By Product And Service, 2020-2029 (Usd Million); Table 58 Canada Ion Torrent Platforms In Whole Exome Sequencing Market, By Product And Service, 2020-2029 (Usd Million); Table 59 Canada Kits In Whole Exome Sequencing Market, By Product And Service, 2020-2029 (Usd Million); Table 60 Canada Services In Whole Exome Sequencing Market, By Product And Service, 2020-2029 (Usd Million); Table 61 Canada Whole Exome Sequencing Market, By Application, 2020-2029 (Usd Million); Table 62 Canada Whole Exome Sequencing Market, By End User, 2020-2029 (Usd Million); Table 63 Canada Whole Exome Sequencing Market, By Distribution Channel, 2020-2029 (Usd Million); Table 64 Mexico Whole Exome Sequencing Market, By Component, 2020-2029 (Usd Million); Table 65 Mexico Second-generation Sequencing In Whole Exome Sequencing Market, By Component, 2020-2029 (Usd Million); Table 66 Mexico Whole Exome Sequencing Market, By Product And Service, 2020-2029 (Usd Million); Table 67 Mexico Systems In Whole Exome Sequencing Market, By Product And Service, 2020-2029 (Usd Million); Table 68 Mexico Hiseq Series In Whole Exome Sequencing Market, By Product And Service, 2020-2029 (Usd Million); Table 69 Mexico Ion Torrent Platforms In Whole Exome Sequencing Market, By Product And Service, 2020-2029 (Usd Million); Table 70 Mexico Kits In Whole Exome Sequencing Market, By Product And Service, 2020-2029 (Usd Million); Table 71 Mexico Services In Whole Exome Sequencing Market, By Product And Service, 2020-2029 (Usd Million); Table 72 Mexico Whole Exome Sequencing Market, By Application, 2020-2029 (Usd Million); Table 73 Mexico Whole Exome Sequencing Market, By End User, 2020-2029 (Usd Million); Table 74 Mexico Whole Exome Sequencing Market, By Distribution Channel, 2020-2029 (Usd Million)
List Of Figures: Figure 1 North America Whole Exome Sequencing (Wes) Market: Segmentation; Figure 2 North America Whole Exome Sequencing (Wes) Market: Data Triangulation; Figure 3 North America Whole Exome Sequencing (Wes) Market: Droc Analysis; Figure 4 North America Whole Exome Sequencing (Wes) Market: Regional Vs Country Market Analysis; Figure 5 North America Whole Exome Sequencing (Wes) Market: Company Research Analysis; Figure 6 North America Whole Exome Sequencing (Wes) Market: Interview Demographics; Figure 7 North America Whole Exome Sequencing (Wes) Market: Market Application Coverage Grid; Figure 8 North America Whole Exome Sequencing (Wes) Market: Dbmr Market Position Grid; Figure 9 North America Whole Exome Sequencing (Wes) Market: Vendor Share Analysis; Figure 10 North America Whole Exome Sequencing (Wes) Market: Segmentation; Figure 11 North America Is Anticipated To Dominate The North America Whole Exome Sequencing (Wes) Market And Asia-pacific Is Estimated To Be Growing With The Highest Cagr In The Forecast Period Of 2022 To 2029; Figure 12 Increase In Use Of Wes Technology For New Scientific Applications And Increasing The Preference Of Wes Over Whole-genome Sequencing Is Its Low-cost Sequencing Capability Is Expected To Drive The North America Whole Exome Sequencing (Wes) Market In The Forecast Period Of 2022 To 2029; Figure 13 The Instrument Segment Is Expected To Account For The Largest Share Of The North America Whole Exome Sequencing (Wes) Market In 2022 & 2029; Figure 14 Drivers, Restraints, Opportunities And Challenges Of The North America Whole Exome Sequencing Market; Figure 15 North America Whole Exome Sequencing Market: By Component, 2021; Figure 16 North America Whole Exome Sequencing Market: By Component, 2022-2029 (Usd Million); Figure 17 North America Whole Exome Sequencing Market: By Component, Cagr (2022-2029); Figure 18 North America Whole Exome Sequencing Market: By Component, Lifeline Curve; Figure 19 North America Whole Exome Sequencing Market: By Product And Service, 2021; Figure 20 North America Whole Exome Sequencing Market: By Product And Service, 2022-2029 (Usd Million); Figure 21 North America Whole Exome Sequencing Market: By Product And Service, Cagr (2022-2029); Figure 22 North America Whole Exome Sequencing Market: By Product And Service, Lifeline Curve; Figure 23 North America Whole Exome Sequencing Market: By Application, 2021; Figure 24 Lobal Whole Exome Sequencing Market: By Application, 2022-2029 (Usd Million); Figure 25 North America Whole Exome Sequencing Market: By Application, Cagr (2022-2029); Figure 26 North America Whole Exome Sequencing Market: By Application, Lifeline Curve; Figure 27 North America Whole Exome Sequencing Market: By End User, 2021; Figure 28 North America Whole Exome Sequencing Market: By End User, 2022-2029 (Usd Million); Figure 29 North America Whole Exome Sequencing Market: By End User, Cagr (2022-2029); Figure 30 North America Whole Exome Sequencing Market: By End User, Lifeline Curve; Figure 31 North America Whole Exome Sequencing Market: By Distribution Channel, 2021; Figure 32 North America Whole Exome Sequencing Market: By Distribution Channel, 2022-2029 (Usd Million); Figure 33 North America Whole Exome Sequencing Market: By Distribution Channel, Cagr (2022-2029); Figure 34 North America Whole Exome Sequencing Market: By Distribution Channel, Lifeline Curve; Figure 35 North America Whole Exome Sequencing Market: Snapshot (2021); Figure 36 North America Whole Exome Sequencing Market: By Country (2021); Figure 37 North America Whole Exome Sequencing Market: By Country (2022 & 2029); Figure 38 North America Whole Exome Sequencing Market: By Country (2021 & 2029); Figure 39 North America Whole Exome Sequencing Market: By Component (2022-2029); Figure 40 North America Whole Exome Sequencing Market: Company Share 2021 (%)